Citations 1
P936: TIME TO RESPONSE, DURATION OF RESPONSE, AND PATIENT-REPORTED OUTCOMES WITH DARATUMUMAB PLUS RD VS RD ALONE IN TRANSPLANT-INELIGIBLE PATIENTS WITH NDMM: SUBGROUP ANALYSIS OF THE PHASE 3 MAIA STUDY
Facon, T., Kumar, Seema, Plesner, Torben , Goldschmidt, H., Perrot, A., Venner, Chris , Mace, Joseph R., Tiab, Mourad, Macro, M. , Frenzel, L., Leleu, Xavier , Pei, H., Borgsten, F., Usmani, S. Z., Moreau, Philippe , Bahlis, Nizar Jacques , O’Dwyer, Michael , Weisel, Katja C , Raje, Noopur
HemaSphere | June 23, 2022 | Volume: 6 | Issue: No issue available | Pages: 826-827
